Curriculum Vitae
Jerome A. Yesavage, MD
Office Address: Department of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
Stanford, California 94305
Office Telephone: Voice: (650) 852-3287 FAX: (650) 852-3297
E-mail yesavage@stanford.edu
Web site: http://www.stanford.edu/people/yesavage/
BA 1967-71 Yale University, Philosophy Major
MD 1971-74 Stanford University School of Medicine
7/74-7/75 Internship in Internal Medicine, University of California, Irvine
7/75-7/78 Residency in Psychiatry, Stanford University
7/77-6/78 Psychopharmacology Research Fellow on N.I.M.H. Training Grant
1975-78 Consultant, Acute Inpatient Services, Santa Clara Valley Medical Center, San Jose, California
1977-1996 Chief, Psychiatric Intensive Care Unit Palo Alto Veterans Administration Medical Center
1979-1985 Assistant Professor of Psychiatry, Stanford University
1985-1991 Associate Professor of Psychiatry, Stanford University
1988-1998 Consultant, Pharmacy Medication Review Committee, Atascadero State Hospital
1989-1992 Chair, American Psychiatric Association Council on Aging
1989-present Contributing Editor, Experimental Aging Research
1991-present Editorial Board, Journal of Geriatric Psychiatry and Neurology
1991-present Professor of Psychiatry, Stanford University
1992-1993 Editorial Board, Journal of the American Geriatrics Society
1995-2003 Editorial Board, Journal of Mental Health and Aging
1996-2001 Chief, Inpatient Psychiatry, VA Palo Alto Health Care System
1998-present Director, Sierra-Pacific MIRECC (Mental Illness Research, Education, and Clinical Center), VA Palo Alto Health Care System
2001-2002 Acting Associate Chief of Staff for Mental Health and Chief of Psychiatry, VA Palo Alto Health Care System
2002-present Associate Chief of Staff for Mental Health and Chief of Psychiatry, VA Palo Alto Health Care System
2002-present Editorial Board, Annual Review of Gerontology and Geriatrics
California Medical License G29976
Diplomate, American Board of Psychiatry and Neurology (Psychiatry) with
Added Qualifications in Geriatric Psychiatry
1971 Graduated magna cum laude with Honors in Philosophy, Yale University
1974 Class Prize in Psychiatry, Stanford University School of Medicine
1976 Falk Fellow, American Psychiatric Association
1978 American Gerontological Society Traveling Fellowship
1993 Weinberg Award for Excellence in Geriatric Psychiatry, American Psychiatric Association
1993-1996 Advisory Panel on Alzheimer's Disease, United States Congress
1970-71 Research Assistant in Philosophy at Yale University
1973 Research Assistant to Dr. Leo Hollister in pharmacology at Stanford University School of Medicine
1976-77 Resident at Clinical Research Center, Palo Alto Veterans Administration Medical Center
1977-1978 Research Fellow on NIMH Training Grant with Leo Hollister, M.D.
1978-1981 Principal investigator in violence research at Psychiatric Intensive Care Unit, Palo Alto Veterans Administration Medical Center
1980-present Principal investigator in geriatric research at Palo Alto Veterans Administration Medical Center (funded by VA, NIMH, NIA)
1984-present Director, Aging Clinical Research Center (funded by NIMH)
1985-present Principal investigator, aviation and substance abuse research (funded by NIDA, NIAAA, NIA)
1998-present Director, Mental Illness Research Educational and Clinical Center (funded by VA)
2000-present Director, Alzheimer’s Disease Core Center (funded by NIA)
Current Research Projects (Principal Investigator):
Stanford Alzheimer’s Disease Core Center, Source: NIA; Annual Direct Costs: $734,000; Dates of entire project: 11/1/00 – 04/30/06
Age-Related Longitudinal Changes in Aviator Performance; Source: NIA; Annual Direct Costs: $200,000; Dates of entire project: 09/1/95 - 08/31/2006
Memory and Mental Health in Aging; Source: NIMH; Annual Direct Costs: $250,000; Dates of entire project: 02/01/84 - 06/30/2006
1982-present Teaching of medical students and psychiatry residents
1983-1985 NIMH Training Grant "A Training Model for Geriatric Psychiatry"
1986-1989 NIMH Training Grant "Geriatric Psychiatry Training Fellowship"
1988-1997 NIMH Training Grant "A Fellowship in Mental Health, Aging, and Dementias"
2000-present Hub site for VA "Special Fellowship Program in Advanced Psychiatry and Psychology"
1985-1989 Member, Life Course (Aging) peer review section for NIMH Aging proposals
1979-1985 Stanford University School of Medicine, Medical Committee for the Protection of Human Subjects in Research
1982-1988 Stanford University School of Medicine, Clinical Faculty Committee
1998-present Stanford University School of Medicine, Department of Psychiatry, Executive Committee
1976-present American Geriatrics Society
1976-present American Psychiatric Association
(1976-1977) A.P.A. Council on Research and Development
(1977-1980) A.P.A. Task Force on Aging
(1979-1981) A.P.A. Task Force on the 1981 White House Conference on Aging
(1982-1985) A.P.A. Task Force on Forensic Issues in Geriatric Psychiatry
(1986-1992) A.P.A. Council on Aging
(1989-1992) Chair, A.P.A. Council on Aging
1978-present American Alpine Club
1979-present American Association for Geriatric Psychiatry
(1985-1988) Board of Directors
(1985-1991) Chair, Task Force on Board Examinations in Geriatric Psychiatry
1979-present Gerontological Society of America
1982-present International Psychogeriatric Association
1982-present Family Survival Project, Scientific Advisory Council
1983-present American Middle East Gerontological Society
1985-present Aircraft Owners and Pilots Association
1990-present California Trout
(2000-present) Board of Governors
2000-present EthicAd.org National Advisory Board
French: read, write, and speak; Spanish: read
Computer programming languages: FORTRAN, Pascal, C
Commercial pilot, single engine land and instrument ratings
O'Hara R, Schröder CM, Kraemer HC, Kryla N, Cao C, Miller E, Schatzberg AF, Yesavage JA, Murphy GM: Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE e4 carriers. Neurology 65: 642-644, 2005.
Wisor JP, Edgar DM, Yesavage J, Ryan HS, McCormick CM, Lapustea N, Murphy GM, Jr: Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's Disease: A role for cholinergic transmission. Neuroscience 131: 375-385, 2005.
Taylor JL, Kraemer HC, Noda A, Friedman L, Zarcone V, Tinklenberg JR, Yesavage JA: On Disentangling States vs. Traits: Demonstration of a New Technique using the Alzheimer's Disease Assessment Scale. Alzheimer Disease and Associated Disorders 16:254-260, 2002
Yesavage JA, O'Hara R, Kraemer HC, Noda A, Taylor JL, Ferris S, Gély-Nargeot M-C, Rosen A, Friedman L, Sheikh J, Derouesné C: Modeling the prevalence and incidence of Alzheimer's Disease and mild cognitive impairment. Journal of Psychiatric Research 36:281-286, 2002
Rosen CS, Chow HC, Greenbaum MA, Finney J, Moos RH, Sheikh JI, Yesavage JA: How well are clinicians following dementia practice guidelines?. Alzheimer's Disease and Associated Disorders 16: 15-23, 2002.
Yesavage JA, Taylor JL, Kraemer HC, Noda A, Friedman L, Tinklenberg JR: Sleep/Wake cycle disturbance in Alzheimer's disease: How much is due to an inherent trait? International Psychogeriatrics 14: 73-81, 2002.
Ford JM, Askari N, Gabrieli J, Mathalon DH, Tinklenberg JR, Menon V, Yesavage JA: Event-related brain potential evidence of spared knowledge in Alzheimer's Disease. Psychology and Aging 16: 161-176, 2002.
Fama R, Shear PK, Marsh L, Yesavage JA, Tinklenberg JR, Lim KO, Pfefferbaum A, Sullivan EV: Remote memory for public figures in Alzheimer's disease: Relationships to regional cortical and limbic brain volumes. Journal of the International Neuropsychological Society 7: 384-390, 2001.
Tinklenberg J, Newkirk L, Thompson J, Ross L, Davies H, Shakoori R, Taylor J, O'Hara R, Kraemer H, Yesavage J, and the Alzheimer's Disease Research Centers of California: Donepezil treatment of Alzheimer's disease patients in California clinical practice: One-year follow up. European Journal of Neuropsychopharmacology 11: S317, 2001.
Murphy GM, Claassen JD, DeVoss JJ, Pascoe N, Taylor JL, Tinklenberg JR, Yesavage JA: Rate of cognitive decline in Alzheimer's Disease is accelerated by the interleukin-1a-889*1 allele. Neurology 56: 1595-1597, 2001.
Friedman L, Benson K, Noda A, Wicks D, Yesavage J: Abstract: Comparison of two sleepiness measures in older insomnia complainers. Sleep 24: A349, 2001.
Dodel RC, Du Y, Bales K, Gao F, Eastwood B, Glazier B, Zimmer R, Cordell B, Hacke A, Evans R, Gallagher-Thompson D, Thompson LW, Tinklenberg JR, Pfefferbaum A, Sullivan EV, Yesavage J, Altstiel L, Gasser T, Farlow M, Murphy GM, Paul SM: Alpha2 macroglobulin and the risk of Alzheimer’s Disease. Neurology 54: 438-444, 2000.
Fama R, Sullivan EV, Shear PK, Cahn-Weiner DA, Marsh L, Lim KO, Yesavage JA, Tinklenberg JR, Pfefferbaum A: Structural brain correlates of verbal and nonverbal fluency measures in Alzheimer's Disease. Neuropsychology 14: 29-40, 2000.
Kahle PJ, Jakowec M, Teipel SJ, Hampel H, Petzinger GM, Di Monte DA, Silverberg GD, Moller HJ, Yesavage JA, Tinklenberg JR, Shooter EM, Murphy GM: Combined assessment of tau and neuronal thread protein in Alzheimer's Disease CSF. Neurology 54: 1498-1504, 2000.
Fama R, Sullivan EV, Shear PK, Cahn-Weiner DA, Marsh L, Lim KO, Yesavage JA, Tinklenberg JR, Pfefferbaum A: Structural brain correlates of verbal and nonverbal fluency measures in Alzheimer's Disease. Neuropsychology 14: 29-40, 2000.
O'Hara R, Mumenthaler MS, Yesavage JA: Update on Alzheimer's Disease: Recent findings and treatment. The Western Journal of Medicine 172: 115-120, 2000.
Brooks JO, Kraemer HC, Yesavage JA: Reply to Rockwood et al.: Re: Modeling decline in Alzheimer's Disease [letter to editor]. International Psychogeriatrics 11: 211-216, 1999.
Cahn-Weiner DA, Sullivan EV, Shear PK, Fama R, Lim KO, Yesavage JA, Tinklenberg JR, Pfefferbaum A: Brain structural and cognitive correlates of Clock Drawing performance in Alzheimer's Disease. Journal of the International Neuropsychological Society 5: 502-509, 1999.
Vaidya CJ, Gabrieli JDE, Monti LA, Tinklenberg JR, Yesavage JA: Dissociation between two forms of conceptual priming in Alzheimer's Disease. Neuropsychology 13: 516-524, 1999.
Kraemer HC, Taylor JL, Tinklenberg JR, Yesavage JA: The stages of Alzheimer's Disease --A Reappraisal. Dementia and Geriatric Cognitive Disorders 9: 299-308, 1998.
Willis SL, Allen-Burge R, Dolan M, Bertrand R, Yesavage J, Taylor JL: Everyday problem solving among individuals with Alzheimer's Disease. Gerontologist 38: 569-577, 1998.
Kraemer HC, Moritz DJ, Yesavage JA: Adjusting Mini Mental State Examination scores for age and educational level to screen for dementia: Correcting bias or reducing validity?. International Psychogeriatrics 10: 43-51, 1998.
Miller TP, Taylor JL, Rogerson S, Mauricio M, Kennedy Q, Schatzberg A, Tinklenberg JR, Yesavage JA: Cognitive and noncognitive symptoms in dementia patients: Relationship to cortisol and dehydroepiandrosterone. International Psychogeriatrics 10: 85-96, 1998.
Brooks JO, Yesavage JA, Carta A, Bravi D: Acetyl L-carnitine slows decline in younger patients with Alzheimer's Disease: A reanalysis of a double-blind, placebo-controlled study using the trilinear approach. International Psychogeriatrics 10: 193-203, 1998.
Yesavage JA, Friedman LF, Kraemer HC, Noda A, Wicks D, Bliwise DL, Sheikh J, Tinklenberg J, Zarcone V: A follow-up study of actigraphic measures in home-residing Alzheimer's Disease patients. Journal of Geriatric Psychiatry and Neurology 11: 7-10, 1998.
Cahn DA, Sullivan EV, Shear PK, Marsh L, Fama R, Lim KO, Yesavage JA, Tinklenberg JR, Pfefferbaum A: Structural MRI correlates of recognition memory in Alzheimer's Disease. Journal of the International Neuropsychological Society 4: 106-114, 1998.
Park SM, Gabrieli JD, Reminger SL, Monti LA, Fleischmann DA, Wilson RS, Tinklenberg JR, Yesavage JA: Preserved priming across study-test picture transformations in patients with Alzheimer's Disease. Neuropsychology 12: 340-352, 1998.
Kraemer HC, Gardner C, Brooks JO, Yesavage JA: Advantages of excluding underpowered studies in meta-analysis: Inclusionist versus exclusionist viewpoints. Psychological Methods 3: 23-31, 1998.
Teri L, Logsdon R, Yesavage JA: Measuring behavior, mood, and psychiatric symptoms in Alzheimer's Disease. Alzheimer Disease and Associated Disorders 11 Suppl 6: 50-59, 1997.
Murphy GM. Taylor JL, Yesavage JA, Tinklenberg JR: The Apolipoprotein e4 allele is associated with increased behavioral disturbance in Alzheimer's Disease [letter to editor]. American Journal of Geriatric Psychiatry 5: 88-89, 1997.
Murphy GM, Taylor JL, Kraemer HC, Yesavage JA, Tinklenberg JR: No association between apolipoprotein E e4 allele and rate of decline in Alzheimer's disease.. American Journal of Psychiatry 154: 603-608, 1997.
Ernst RL, Hay JW, Fenn C, Tinklenberg JR, Yesavage JA: Cognitive function and the costs of Alzheimer's Disease: An exploratory study. Archives of Neurology 54: 687-693, 1997.
Fama R, Sullivan EV, Shear PK, Marsh L, Yesavage JA, Tinklenberg JR, Lim KO, Pfefferbaum A: Selective cortical and hippocampal volume correlates of Mattis Dementia Rating Scale in Alzheimer's Disease. Archives of Neurology 54: 719-728, 1997.
Friedman LF, Kraemer HC, Zarcone V, Sage S, Wicks D, Bliwise D, Sheikh JI, Tinklenberg JR, Yesavage JA: Disruptive behavior and actigraphic measures in home-dwelling patients with Alzheimer's Disease: Preliminary Report. Journal of Geriatric Psychiatry and Neurology 10: 58-62, 1997.
Murphy GM, Sullivan EV, Gallagher-Thompson D, Thompson LW, van Duijn CM, Forno LS, Ellis WG, Jagust WJ, Yesavage J, Tinklenberg JR: No association between the Alpha 1-antichymotrypsin A allele and Alzheimer's Disease. Neurology 48: 1313-1316, 1997.
Robinson D, Bucci J, Fenn HH, Miller T, Tinklenberg JR, Yesavage JA: Erythrocyte sedimentation rate in Alzheimer's Disease. American Geriatrics Sociology 43: 1177-78, 1996.
Ford JM, Woodward SH, Sullivan EV, Isaacks BG, Tinklenberg JR, Yesavage JA, Roth WT: N400 evidence of abnormal responses to speech in Alzheimer's Disease. Electroencephalography and Clinical Neurophysiology 99: 235-246, 1996.
Murphy GM, Yang L, Yesavage JA, Tinklenberg JR: Rate of cognitive decline in Alzheimer's Disease is not affected by the Alpha-1-antichymotrypsin A allele or the CYP2D6 B mutant. Neuroscience Letters 217: 200-202, 1996.
Brooks JO, Yesavage JA: Identification of fast and slow decliners in Alzheimer's Disease: A different approach. Alzheimer Disease and Associated Disorders 9: S19-S25, 1995.
Shear PK, Sullivan EV, Mathalon DH, Lim KO, Davis LF, Yesavage JA, Tinklenberg JR, Pfefferbaum A: Longitudinal volumetric computed tomographic analysis of regional brain changes in normal aging and Alzheimer's Disease. Archives of Neurology 52: 392-402, 1995.
Sullivan EV, Shear PK, Lim KO, Johnson J, Stein M, Yesavage JA, Tinklenberg JR, Pfefferbaum A: Age-related cortical gray matter deficits in Alzheimer's Disease: A volumetric MRI analysis. International Neuropsychological Society 23rd Annual Meeting : , 1995.
Robinson D, Langer A, Casso D, Fenn HH, Yesavage JA: Pancytopenia and valproic acid -- A possible association [letter to editor]. Journal of the American Geriatrics Society 43: 198, 1995.
Kraemer HC, Tinklenberg J, Yesavage JA: "How far" vs "how fast" in Alzheimer's Disease: The question revisited. Archives of Neurology 51: 275-279, 1994.
Robinson D, Omar SJ, Quach M, Yesavage JA, Tinklenberg JR: Oral temperature changes and cognitive decline in Alzheimer patients: A possible association [letter to editor]. Journal of the American Geriatrics Society 42: 1218-1219, 1994.
Yesavage JA, Brooks JO, Taylor JL, Tinklenberg JR: Development of Aphasia, Apraxia, and Agnosia and decline in Alzheimer's Disease. American Journal of Psychiatry 150: 742-747, 1993.
Sullivan EV, Shear PK, Mathalon DH, Lim KO, Yesavage JA, Tinklenberg JT, Pfefferbaum A: Greater abnormalities of brain CSF volumes in younger than older patients with Alzheimer's Disease. Archives of Neurology 50: 359-373, 1993.
Fenn HH, Luby V, Yesavage JA: Subtypes in Alzheimer's Disease and the impact of excess disability: Recent findings. International Journal of Geriatric Psychiatry 8: 67-73, 1993.
Brooks JO, Yesavage JA, Taylor JL, Friedman LF, Tanke ED, Luby V, Tinklenberg JR: Cognitive decline in Alzheimer's Disease: Elaborating on the nature of the longitudinal factor structure of the Mini-Mental State Examination. International Psychogeriatrics 5: 135-146, 1993.
Miller TP, Tinklenberg JR, Brooks JO, Fenn HH, Yesavage JA: Selected psychiatric symptoms associated with rate of cognitive decline in patients with Alzheimer's Disease. Journal of Geriatric Psychiatry and Neurology 6: 235-238, 1993.
Brooks JO, Kraemer HC, Tanke ED, Yesavage JA: The methodology of studying decline in Alzheimer's Disease. Journal of the American Geriatrics Society 41: 623-628, 1993.
Shear PK, Sullivan EV, Mathalon DH, Lim KO, Davis LF, Yesavage JA, Tinklenberg JR, Pfefferbaum A: Abstract: Longitudinal CT study of cerebral CSF volume changes in Alzheimer's Disease. Society for Neuroscience 1992 meeting. 1993.
Bliwise DL, Yesavage JA, Tinklenberg JR: Sundowning and rate of decline in mental function in Alzheimer's Disease. Alzheimer Disease and Associated Disorders 3: 335-341, 1992.
Bliwise DL, Tinklenberg JR, Yesavage JA: Timing of sleep and wakefulness in Alzheimer's Disease patients residing at home. Biological Psychiatry 31: 1163-1165, 1992.
Rybarczyk B, Gallagher-Thompson D, Rodman J, Zeiss A, Gantz FE, Yesavage JA: Applying Cognitive-Behavioral psychotherapy to the chronically ill elderly: Treatment issues and case illustration. International Psychogeriatrics 4: 127-140, 1992.
Gallagher-Thompson D, Brooks JO, Bliwise D, Leader J, Yesavage JA: The relations among caregiver stress, "Sundowning" symptoms, and cognitive decline in Alzheimer's Disease. Journal of the American Geriatrics Society 40: 807-810, 1992.
Mathalon DH, Sullivan EV, Shear PK, Lim KO, Sagar HJ, Yesavage JA, Tinklenberg JR, Pfefferbaum A: Abstract: Profile analysis of regional brain differences in Alzheimer's Disease and Parkinson's Disease measured with quantitative CT analysis. Society for Neuroscience. 1992.
Winograd CH, Jacobsen DH, Butterfield GE, Cragen E, Edler LA, Taylor BS, Yesavage JA: Nutritional intake in patients with senile dementia of the Alzheimer's type. Alzheimer Disease and Associated Disorders 5: 173-180, 1991.
Miller TP, Tinklenberg JR, Brooks JO, Yesavage JA: Cognitive decline in patients with Alzheimer's Disease: Differences in patients with and without extrapyramidal signs. Alzheimer Disease and Associated Disorders 5: 251-256, 1991.
Yesavage JA, Taylor B: Anxiety and dementia. In: Carl Salzman, Anxiety in the Elderly: Treatment and Research. pp. 79-85, New York: Springer Publishing Co., Inc., 1991.
Winograd CH, Jacobsen DH, Minkoff JR, Peabody CA, Taylor BS, Widrow L, Yesavage JA: Blood glucose and insulin response in patients with senile dementia of the Alzheimer's type. Biological Psychiatry 30: 507-511, 1991.
Yesavage JA, Brooks JO: On the importance of longitudinal research in Alzheimer's Disease. Journal of the American Geriatrics Society 39: 942-944, 1991.
Sullivan EV, Pfefferbaum A, Zipursky RB, Jernigan TL, Tinklenberg JR, Yesavage JA: A CT study of brain-behavior relationships in Alzheimer's Disease. Journal of Clinical Experimental Neuropsychology 12: 21, 1990.
Pfefferbaum A, Sullivan EV, Jernigan TL, Zipursky RB, Rosenbloom M, Yesavage JA, Tinklenberg JR: A quantitative analysis of CT and cognitive measures in normal aging and Alzheimer's Disease. Psychiatry Research 35: 115-136, 1990.
Lim K, Yesavage JA, Keelaghan E: Three dimensional magnetic resonance images of the brain. In: K. Hasegawa, A. Homma, Psychogeriatrics: Biomedical and Social Advances (Selected proceedings of the 4th Congress of the IGA). pp. 161-165, Amsterdam: Excerpta Medica, 1990.
Bliwise DL, Tinklenberg J, Yesavage J, Davies H, Pursley A, Petta D, Widrow L, Guilleminault C, Zarcone V, Dement WC: REM latency in Alzheimer's Disease. Biological Psychiatry 25: 320-328, 1989.
Bliwise DL, Yesavage JA, Tinklenberg J, Dement WC: Sleep apnea in Alzheimer's Disease. Neurobiology of Aging 10: 343-346, 1989.
Taylor JE, Tinklenberg JR, Eng LF, Yesavage JA, Vinogradov S, Davies HG, Gonzalez-DeWhitt PA, Frossard PM: Association study between Alzheimer's Disease and restriction fragment length polymorphisms at the human amyloid beta protein gene locus. Molecular Biology & Medicine 5: 167-172, 1988.
Taylor JE, Gonzalez-DeWhitt PA, Fuller F, Cordell B, Tinklenberg JR, Davies HD, Eng LF, Yesavage JA, Frossard PM: Human amyloid beta protein gene locus: HaeIII RFLP. Nucleic Acids Research 16: 7217, 1988.
Taylor JE, Cordell B, Fuller F, Gonzalez-DeWhitt PA, Tinklenberg JR, Davies HD, Eng LF, Yesavage JA, Frossard PM: EcoT14I RFLP found at the human amyloid beta protein gene locus. Nucleic Acids Research 16: 6259, 1988.
Tinklenberg JR, Taylor JE, Eng LF, Yesavage JA, Vinogradov S, Gonzalez PA, Davies HD, Frossard PM: Associations between Alzheimer's Disease and RFLPs at the human amyloid beta protein gene locus. Psychopharmacology Bulletin 24: 489-491, 1988.
Yesavage JA, Poulsen SL, Sheikh JI, Tanke ED: Rates of change of common measures of impairment in Senile Dementia of the Alzheimer's type. Psychopharmacology Bulletin 24: 531-534, 1988.
Taylor JE, Cordell B, Fuller F, Gonzalez-DeWhitt PA, Tinklenberg JR, Davies HG, Eng LF, Yesavage JA, Frossard PM: EcoT141 RFLP found at the human amyloid beta protein gene locus. Psychopharmacology Bulletin 16: 625-629, 1988.
Derousné C, Yesavage JA: Controverses: Maladie d'Alzheimer et dépression. Visages de la dépression: Revue scientifique trimestrielle Roche 12: 16-20, 1988.
Peabody CA, Minkoff JR, Davies HD, Winograd CH, Yesavage JA, Tinklenberg JR: Thyrotropin-releasing hormone stimulation test and Alzheimer's Disease. Biological Psychiatry 21: 553-556, 1986.
Bliwise DL, Tinklenberg J, Davies H, Pursley A, Petta D, Yesavage J, Widrow L, Guilleminault C, Zarcone V, Dement WC: Abstract: Sleep patterns in Alzheimer's Disease. Sleep Researchvol. 15. 1986.
Yesavage JA, Westphal J, Rush L: Senile dementia: Combined pharmacologic and psychologic treatments. Journal of the American Geriatrics Society 29: 164-171, 1981.
O'Hara R, Brooks JO, Friedman LF, Kishan S, Kraemer HC, Yesavage JA: Long-term effects of mnemonic training in 112 community-dwelling older adults. Journal of Gerontology: Psychological Sciences (In Press).
O'Hara R, Schröder CM, Bloss C, Bailey AM, Alyeshmerni AM, Mumenthaler MS, Friedman LF, Yesavage JA: Hormone replacement therapy and longitudinal cognitive performance in postmenopausal women. American Journal of Geriatric Psychiatry 13: 1107-1110, 2005.
Rosen A, Gabrieli J, Stoub T, Prull MW, O'Hara R, Yesavage JA, deToleda-Morrell L: Relating medial temporal lobe volume to frontal fMRI activation for memoryencoding in older adults. Cortex 41: 595-602, 2005.
Taylor JL, O'Hara R, Mumenthaler MS, Rosen AC, Yesavage JA: Cognitive ability, expertise, and age differences in following air-traffic control instructions. Psychology and Aging 20: 117-133, 2005.
Brooks JO, Friedman LF, Yesavage JA: Use of an external mnemonic to augment the efficacy of an internal mnemonic in older adults. International Psychogeriatrics 15: 59-67, 2003.
Rosen AC, Prull MW, Gabrieli JD, Stoub T, O'Hara R, Friedman L, Yesavage JA, deToledo-Morrell L: Differential associations between entorhinal and hippocampal volumes and memory performance in older adults. Behav Neurosci117(6):1150-60, 2003
Rosen AC,Prull MW, O'Hara R, Race E, Desmond J, Glover G, Yesavage JA, Gabrieli JDE: Variable effects of aging on frontal-lobe contributions to memory. Neuroreport 13: 2425-2428, 2003.
Braver TS, Barch DM, Keys BA, Carter CS, Cohen JD, Kaye JA, Janowsky JS, Taylor SF, Yesavage JA, Mumenthaler MS, Jagust WJ, Reed BR: Context processing in older adults: Evidence for a thoery relating congnitive control to neurobiology in health aging. Journal of Experimental Psychology: General 130: 746-763, 2001.
Pearman A, Friedman LF, Brooks JO, Yesavage JA: Hearing impairment and serial word recall in older adults. Experimantal Aging Research 26: 383-391, 2000.
Yesavage JA, Brooks JO, Lapp D, O'Hara R, Mancilla-Koch C, Friedman L: Training to improve memory performance in Hispanic community-dwelling older adults. Clinical Gerontologist 21: 61-65, 1999.
Brooks JO, Friedman LF, Pearman AM, Grey C, Yesavage JA: Mnemonic training in older adults: Effects of age, length of training, and type of cognitive pretraining. International Psychogeriatrics 11: 75-84, 1999.
McKitrick LA, Friedman LF, Brooks JO, Pearman A, Kraemer HC, Yesavage JA: Predicting response of older adults to mnemonic training: Who will benefit?. International Psychogeriatrics 11: 289-300, 1999.
Yesavage JA: Convergent behavioral and neuropsychological evidence for a distinction between identification and production forms of repetition priming. Journal of Experimental Psychology: General 128: 479-498, 1999.
Brooks JO, Gibson JM, Friedman LF, Yesavage JA: How to drastically reduce priming in word stem completion -- and still present the word. Memory & Cognition 27: 208-219, 1999.
Thompson JL, Gylfadotir UK, Butterfield GE, Yesavage JA, Marcus R, Hintz R, Pearman A, Hoffman A: Effects of Human Growth Hormone, insulin-like Growth Factor I, and diet and exercise on body composition of obese postmenopausal women. Journal of Clinical Endocrinology & Metabolism 83: 1477-1484, 1998.
O'Hara R, Yesavage JA, Kraemer HC, Mauricio M, Friedman LF, Murphy GM: The APOE e4 allele is associated with decline on delayed recall performance in community-dwelling older adults. Journal of the American Geriatrics Society 46: 1493-1498, 1998.
McKitrick LA, Friedman LF, Thompson LW, Gray C, Yesavage JA: Feasibility and psychometric description of a paced auditory serial addition task adapted for older adults. Journal of Clinical Geropsychology 3: 57-71, 1997.
McKitrick LA, Friedman LF, Thompson LW, Gray C, Yesavage JA: Abstract: Psychometric properties of the PASAT adapted for use with older adults. Gerontology Society of America 48th Annual Meeting. 1995.
Robinson D, Friedman LF, Marcus R, Tinklenberg JR, Yesavage JA: Estrogen replacement therapy and memory in normal older women. Journal of the American Geriatrics Society 42: 919-922, 1994.
Brooks JO, Friedman LF, Yesavage JA: A study of the problems older adults encounter when using a mnemonic technique. International Psychogeriatrics 5: 57-65, 1993.
Brooks JO, Friedman LF, Gibson JM, Yesavage JA: Spontaneous mnemonic strategies used by older and younger adults to remember proper names. Memory 1: 393-407, 1993.
Gibson JM, Brooks JO, Friedman LF, Yesavage JA: Typography manipulations can affect priming of word stem completion in older adults. Psychology and Aging 8: 481-489, 1993.
Yesavage JA, Lapp DC: Age-Associated Memory Impairment: Nonpharmacologic therapy. In: Crook T, Gershon S, Diagnosis and Treatment of Adult-Onset Cognitive Disorders. pp. 222-233, Old Saybrook, Connecticut: Psymark Communications, Inc., 1991.
Crook TH, Tinklenberg J, Yesavage J, Petrie W, Nunzi MG, Massari DC: Effects of phosphatidylserine in age-associated memory impairment. Neurology 41: 644-649, 1991.
Yesavage JA: Age-Associated Memory Impairment: Conceptual background and treatment approaches. In: M. Bergener, M. Ermini, HB Stähelin, Challenges in Aging: The 1990 Sandoz Lectures in Gerontology. pp. 53-72, London: Academic Press (Harcourt Brace Jovanovich), 1990.
Yesavage JA: Attention versus retention and geriatric psychopharmacology. In: M. Bergener, SI. Finkel, Clinical and Scientific Psychogeriatrics: The Interface of Psychiatry and Neurologyvol. 2. pp. 45-60, New York: Springer Publishing Company, 1990.
Gratzinger P, Sheikh JI, Friedman LF, Yesavage JA: Cognitive interventions to improve face-name recall: The role of personality trait differences. Developmental Psychology 26: 889-893, 1990.
Yesavage JA, Sheikh JI, Friedman LF, Tanke E: Learning mnemonics: The roles of aging and subtle cognitive impairment. Psychology and Aging 5: 133-137, 1990.
Yesavage JA: Techniques for cognitive training of memory in age-associated memory impairment. Archives of Gerontology and Geriatrics Suppl 1: 185-190, 1989.
Hill RD, Yesavage JA, Sheikh J, Friedman LF: Mental status as a predictor of response to memory training in older adults. Educational Gerontology 15: 633-639, 1989.
Yesavage JA, Sheikh JI: Mnemonics as modified for use in the elderly. In: Poon LW, Rubin DC, Wilson BA, Everyday Cognition in Adulthood and Late Life. pp. , New York: Cambridge University Press, 1989.
Finkel SI, Yesavage JA: Learning Mnemonics: A preliminary evaluation of a computer-aided instruction package for the elderly. Experimental Aging Research 15: 199-201, 1989.
Yesavage JA, Sheikh JI, Tanke ED, Hill RD: Response to memory training and individual differences in verbal intelligence and state anxiety. American Journal of Psychiatry 145: 636-639, 1988.
Hill RD, Sheikh JI, Yesavage JA: Pretraining enhances mnemonic training in elderly adults. Experimental Aging Research 14: 207-211, 1988.
Yesavage JA: Techniques d'entrainement cognitif de la memoire lors des deficits mnesiques du sujet age. Memoire et Vieillissement cerebral 1: 1-6, 1988.
Hill RD, Sheikh JI, Yesavage JA: The effect of mnemonic training on perceived recall confidence in the elderly. Experimental Aging Research 13: 185-188, 1987.
Yesavage JA: Possibilite d'amelioration des performances du cereau normal: Traitements nonpharmacologiques pour les problemes de memoire associes au viellissement normal. Gedachtnistraining/Entrainement de la memoire 49: 45-61, 1987.
Yesavage JA: Attention versus retention and cognitive loss in the elderly. Proceedings of the Second Asian Seminar on Aging: Update on Treatment of the Elderly. : Excerpta Medica Asia Ltd., 1987.
Yesavage JA: Age-Associated Memory Impairment. In: , Psychogeriatrics: Selected Abstracts from the Third Congress of the International Psychogeriatric Association. pp. 70-71, : Altier & Maynard Communications Inc., 1987.
Hill RD, Evankovich K, Sheikh JI, Yesavage JA: Imagery mnemonic training in a patient with Primary Degenerative Dementia. Psychology and Aging 2: 204-205, 1987.
Yesavage JA: Methods to aid memory in the aged. The Western Journal of Medicine 147: 72-73, 1987.
Sheikh JI, Hill RD, Yesavage JA: Long-term efficacy of cognitive training for age-associated memory impairment: A 6-month follow-up study. Developmental Neuropsychology 2: 413-421, 1986.
Rose TL, Yesavage JA, Hill RD, Bower GH: Priming effects and recognition memory in young and elderly adults. Experimental Aging Research 12: 31-37, 1986.
Yesavage JA: Non-pharmacologic treatments for memory losses with normal aging. American Journal of Psychiatry 142: 600-605, 1985.
Sheikh JI, Yesavage JA: Toward a practical approach to memory problems. Contemporary Psychology 30: 686-87, 1985.
Yesavage JA: Relaxation and memory training in 39 elderly patients. American Journal of Psychiatry 141: 778-781, 1984.
Taylor LL, Yesavage JA: Cognitive retraining programs for the elderly: A case study of cost/benefit issues. Clinical Gerontologist 2: 51-63, 1984.
Yesavage JA, Rose TL: Semantic elaboration and the method of loci: A new trip for older learners. Experimental Aging Research 10: 155-159, 1984.
Yesavage JA, Rose TL: The effects of a face-name mnemonic in young, middle-aged, and elderly adults. Experimental Aging Research 10: 55-57, 1984.
Yesavage JA, Jacob R: Effects of relaxation and mnemonics on memory, attention, and anxiety in the elderly. Experimental Aging Research 10: 211-214, 1984.
Rose TL, Yesavage JA: Differential effects of a list-learning mnemonic in three age groups. Gerontology 29: 293-298, 1983.
Yesavage JA: Imagery pretraining and memory training in the elderly. Gerontology 29: 271-275, 1983.
Yesavage JA, Rose TL, Bower GH: Interactive imagery and affective judgments improve face-name learning in the elderly. Journal of Gerontology 38: 197-203, 1983.
Yesavage JA: Opportunities for and obstacles to treatments for dementias. Guest Editorial. Journal of the American Geriatrics Society 31: 59-60, 1983.
Yesavage JA, Tinklenberg JR: Tests d'attention, de memoire et de performance motrice sur ordinateur appliques a la recherche en geriatrie. La Presse Medicale 12: 3170-3172, 1983.
Yesavage JA, Rose TL: Concentration and mnemonic training in elderly subjects with memory complaints: A study of combined therapy and order effects. Psychiatry Research 9: 157-167, 1983.
Yesavage JA, Karasu TB: Psychotherapy with elderly patients. American Journal of Psychotherapy 36: 41-55, 1982.
Yesavage JA: Degree of dementia and improvement with Memory Training. Clinical Gerontologist 1: 77-80, 1982.
Welden S, Yesavage JA: Behavioral improvement with relaxation training in senile dementia. Clinical Gerontologist 1: 45-49, 1982.
Yesavage JA, Rose TL, Spiegel D: Relaxation training and memory improvement in elderly normals: Correlation of anxiety ratings and recall improvement. Experimental Aging Research 8: 195-198, 1982.
Yesavage JA: A Kantian critique of cognitive psychotherapy. American Journal of Psychotherapy 34: 99-106, 1980.
Mohs R, Davis KL, Tinklenberg JR, Hollister LE, Yesavage JA, Kopell BS: Choline chloride treatment of memory deficits in the elderly. American Journal of Psychiatry 136: 1275-1277, 1979.
Newkirk LA, Kim JM, Thompson JM, Tinklenberg JR, Yesavage JA, Taylor JL: Validation of a 26-point telephone version of the Mini-Mental State Examination. J Geriatr Psychiatry Neurol17(2):81-7, 2004
Coman E, Moses JA, Kraemer HC, Friedman LF, Benton AL, Yesavage JA: Interactive influences on BVRT performance level: Geriatric considerations. Archives of Clinical Neuropsychology 17: 595-610, 2002.
O’Hara R, Thompson JM, Kraemer HC, Fenn C, Taylor JL, Ross L, Yesavage JA, Bailey AM, Tinklenberg JR: Which Alzheimer's Disease patients are at risk for rapid cognitive decline?. Journal of Geriatric Psychiatry and Neurology 15: 1-6, 2002.
Noda A, Kraemer HC, Yesavage JA, Periyakoil VS: How many raters are needed for a reliable diagnosis?. International Journal of Methods in Psychiatric Research 10: 119-125, 2001.
O'Hara R, Yesavage JA: The Geriatric Depresssion Scale: It's development and recent application. In: Copeland J, Abou-Saleh M, Balzer D, (eds), Principals and Practice of Geriatric Psychiatry - 2nd Edition. Sussex: John Wiley & Sons, 2001.
Kraemer HC, Yesavage JA, Taylor JL, Kupfer D: How can we learn about developmental processes from cross-sectional studies, or can we?. American Journal of Psychiatry 157: 163-171, 2000.
Mauricio M, O'Hara R, Yesavage JA, Friedman LF, Kraemer HC, Van Der Water M, Murphy GM: A longitudinal study of apolipoprotein-e genotype and depressive symptoms in community-dwelling older adults. American Journal of Geriatric Psychiatry 8: 1-4, 2000.
Taylor JL, O’Hara R, Mumenthaler MS, Yesavage JA: Relationship of CogScreen-AE to flight simulator performance and pilot age. Aviation, Space, and Environmental Medicine 71: 373-380, 2000.
Coman E, Moses J, Kraemer HC, Friedman LF, Benton A, Yesavage JA: Geriatric performance on the Benton Visual Retention Test: Demographic and diagnostic considerations. The Clinical Neuropsychologist 13: 66-77, 1999.
Fountoulakis KN, Tsolaki M, Iacovides A, Yesavage JA, O'Hara R, Kazis A: The validation of the short form of the Geriatric Depression Scale (GDS) in Greece. Aging 11: 367-372, 1999.
McKitrick LA, Friedman LF, Pearman A, Yesavage JA: Ecologically-valid stimuli in memory training and assessment. Clinical Gerontologist 17: 58-62, 1997.
Ford JM, Roth WT, Isaacks BG, Tinklenberg JR, Yesavage JA, Pfefferbaum A: Automatic and effortful processing in aging and dementia: Event-related brain potentials. Neurobiology of Aging 18: 169-180, 1997.
Brooks JO, Kraemer HC, Tanke ED, Yesavage JA: The Trilinear Program. 41: 623-628, 1993.
Yesavage JA: Differential diagnosis between depression and dementia. American Journal of Medicine 94: 23s-28s, 1993.
Segel S, Tam HC, Yesavage JA, Yeo G: Determining the effectiveness of DSM-III-R criteria for major depression when applied to Chinese elders. Clinical Gerontologist 13: 3-16, 1993.
Mitchell J, Mathews HF, Yesavage JA: A multidimensional examination of depression among the elderly. Research on Aging 15: 198-219, 1993.
Yesavage JA: Depression in the elderly: How to recognize masked symptoms and choose appropriate therapy. Postgraduate Medicine 9: 255-8, 261, 1992.
Sheikh JI, Yesavage JA, Brooks JO, Friedman LF, Gratzinger P, Hill RD, Zadeik A, Crook T: Proposed factor structure of the Geriatric Depression Scale. International Psychogeriatrics 3: 23-28, 1991.
Yesavage JA: Geriatric Depression Scale: Consistency of depressive symptoms over time. Perceptual and Motor Skills 73: 1, 1991.
Tinklenberg JR, Brooks JO, Tanke ED, Khalid K, Poulsen SL, Kraemer HC, Gallagher D, Thornton JE, Yesavage JA: Factor analysis and preliminary validation of the Mini-Mental State Examination from a longitudinal perspective. International Psychogeriatrics 2: 123-134, 1990.
Yesavage JA: Geriatric Depression Scale. Psychopharmacology Bulletin 24: 709 -711, 1988.
Yesavage JA: The use of self-rating depression scales in the elderly. In: LW Poon, et al (Eds), The Handbook of Clinical Memory Assessment of Older Adults. pp. 213-217, Washington DC: American Psychological Association, 1986.
Brink TL, Carter MA, Janson E, Jones JE, Love D, Menn ME, Peratis T, Yesavage JA: Paranoia in later life: An abortive attempt to construct a scale. Clinical Gerontologist 3: 50-52, 1985.
Yesavage JA: Problems in the care of neuropsychiatric disorders in the aged. Proceedings of the 17th International Congress of Internal Medicine : , 1985.
Yesavage JA, Widrow LA: Senile dementia: Psychological and behavioral treatments. In: , Aging 200: Our Health Care Destiny. Psychosocial Issues. pp. 477-492, New York: Springer-Verlag, Inc., 1984.
Yesavage JA, Brink TL, Rose TL, Adey MB: The Geriatric Depression Rating Scale: Comparison with other self-report and psychiatric rating scales. In: T Crook, S Ferris, R Bartus (Eds), Assessment in Geriatric Psychopharmacology. pp. 153-165, New Canaan, CT: Mark Powley Associates, 1984.
Miller T, Davies H, Yesavage JA, Tinklenberg JR: Presenile dementia associated with elevated aluminum and zinc levels: A case report. Clinical Gerontologist 2: 55-59, 1984.
Yesavage JA: Senile dementia treatments. In: C Van Dyke, L Temoshok, L Zegans (Eds), Emotions in Health and Illness: Applications to Clinical Practice. pp. 49-63, San Diego: Grune and Stratton, 1984.
Yesavage JA: Conceptos actuales sobre el tratamiento de la demencia senil. Rev Esp Geriatr y Gerontal 19: 31-40, 1984.
Baker FM, Perr IN, Yesavage JA: An overview of legal issues in geriatric psychiatry. Task Force Report of the American Psychiatric Association, #23. Washington DC: American Psychiatric Association, 1984.
Yesavage JA, Adey MB: Design aspects of studies of drugs claimed to improve cognitive function in the aged.. Envejecimiento Cerebral Nuevos Avances : 98-102, 1983.
Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey MB, Leirer VO: Development and validation of a geriatric depression screening scale: A preliminary report. Journal of Psychiatric Research 17: 37-49, 1983.
Kraemer HC, Peabody P, Tinklenberg JR, Yesavage JA: Mathematical and empirical development of a test of memory for clinical and research use. Psychological Bulletin 94: 367-380, 1983.
Brink TL, Yesavage JA, Lum O, Heersema P, Adey MB, Rose TL: Screening tests for geriatric depression. Clinical Gerontologist 1: 37-44, 1982.
Yesavage JA, Adey MB: Design aspects of studies of drugs claimed to improve cognitive function in the aged. Journal of Psychiatric Treatment and Evaluation 3: 545-549, 1981.
Yesavage JA, Adey MB, Werner PD: Development of a geriatric behavioral self-assessment scale. Journal of the American Geriatrics Society 29: 285-288, 1981.
Finkel S, Borson S, Shamoian C, Stein E, Yesavage JA, Rennick J, Fine T: The 1981 White House Conference on Aging. Task Force Report of the APA 1981 White House Conference on Aging. Washington DC: American Psychiatric Association, 1981.
Yesavage JA: Dementia: Differential diagnosis and treatment. Geriatrics 34: 51-59, 1979.
Spira AP, Friedman L, Flint A, Sheikh JI: Interaction of sleep disturbances and anxiety in later life: Perspectives and recommendations for future research. Journal of Geriatric Psychiatry and Neurology 18: 109-115, 2005.
Benson K, Friedman L, Noda A, Wicks D, Wakabayashi E, Yesavage J: The measurement of sleep by actigraphy: Direct comparison of 2 commercially available actigraphs in a nonclinical population. Sleep27(5):986-9, 2004
Yesavage JA, Friedman L, Kraemer H, Tinklenberg JR, Salehi A, Noda A, Taylor JL, O'Hara R, Murphy G: Sleep/wake disruption in Alzheimer's disease: APOE status and longitudinal course. J Geriatr Psychiatry Neurol17(1):20-4, 2004
Yesavage JA, Friedman L, Ancoli-Israel S, Bliwise D, Singer C, Vitiello MV, Monjan AA, Lebowitz B: Development of diagnostic criteria for defining sleep disturbance in Alzheimer's Disease. Journal of Geriatric Psychiatry and Neurology 16: 131-139, 2003.
Ripley B, Overeem S, Fujiki N, Nevsimalova S, Uchina M, Yesavage JA, DiMonte D, Dohi K, Melberg A, Lammers GJ, Nishida Y, Roelandse FWC, Hungs M, Mignot E, Nishino S: CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 57: 2253-2258, 2001.
Thu TT, Hernandez B, Friedman LF, Kushida CK, Mahapatra D, Guilleminault C, Yesavage J: Abstract: Major exclusion factors for elderly subjects in primary insomnia research studies. Sleep 24: A346, 2001.
Friedman LF, Benson K, Noda A, Zarcone V, Wicks DA, O'Connell K, Brooks JO, Bliwise DL, Yesavage JA: An actigraphic comparison of Sleep Restriction and Sleep Hygiene treatments for insomnia in older adults. Journal of Geriatric Psychiatry and Neurology 13: 17-27, 2000.
Benson KL, Friedman L, Zarcone VP, Yesavage JA: Abstract: Daytime sleepiness in older insomnia complainers. Sleep 23: A324, 2000.
Friedman L, Benson K, Noda A, Wicks D, Zarcone VP, Yesavage JA: Abstract: A comparison of SDQ responses of healthy older insomnia complainers and normal controls. Sleep 23: A318, 2000.
Taylor JL, Friedman LF, Sheikh JI, Yesavage JA: Assessment and management of “Sundowning” phenomena. Seminars in Clinical Neuropsychiatry 2: 113-122, 1997.
Bliwise DL, Friedman LF, Nekich JC, Yesavage JA: Prediction of outcome in behaviorally based insomnia treatments. Journal of Behavioral Therapy and Experimental Psychology 26: 17-23, 1995.
Friedman LF, Brooks JO, Bliwise DL, Yesavage JA, Wicks DS: Perceptions of life stress and chronic insomnia in older adults. Psychology and Aging 10: 352-357, 1995.
Friedman LF, Brooks JO, Bliwise DL, Yesavage JA: Insomnia in older adults: Relations to depression and anxiety. American Journal of Geriatric Psychiatry 1: 153-159, 1993.
Bliwise DL, Friedman LF, Yesavage JA: Depression as a confounding variable in the estimation of habitual sleep time. Journal of Clinical Psychology 49: 471-477, 1993.
Brooks JO, Friedman LF, Bliwise DL, Yesavage JA: Use of the Wrist Actigraph to study insomnia in older adults. Sleep 16: 151-155, 1993.
Friedman LF, Bliwise DL, Tanke ED, Salom SR, Yesavage JA: A survey of self-reported poor sleep and associated factors in older individuals. Behavior, Health, and Aging 2: 13-20, 1992.
Friedman LF, Bliwise DL, Yesavage JA, Salom SR: A preliminary study comparing sleep restriction and relaxation treatments for insomnia in older adults. Journal of Gerontology 46: 1-8, 1991.
Bliwise DL, Yesavage JA, Sink V, Widrow LA, Dement WC: Depressive symptoms and impaired respiration in sleep. Journal of Consulting and Clinical Psychology 54: 734-735, 1986.
Bliwise DL, Tinklenberg J, Davies H, Pursley A, Petta D, Yesavage J, Widrow L, Guilleminault C, Zarcone V, Dement WC: Variations in dementia over time: Overnight change in face-hand test (FHT) and sleep-related hypoxemia. Gerontologist : , 1985.
Yesavage JA, Bliwise D, Guilleminault C, Carskadon M, Dement WC: Preliminary Communication: Intellectual deficit and sleep-related respiratory disturbance in the elderly. Sleep 8: 30-33, 1985.
Aulakh JS, Hawkins JW, Athwal HS, Sheikh JI, Yesavage J, Tinklenberg JR: Tolerability and effectiveness of lamotrigine in complex elderly patients. Journal of Geriatric Psychiatry and Neurology 18: 8-11, 2005.
O'Hara R, Derouesné C, Fountoulakis KN,, Yesavage JA: Therapeutic approaches to age-associated neurocognitive disorders. In: , Dialogues in Clinical Neuroscience. Cerebral Ageing: Concepts and Assessments, vol. 3. pp. 191-213, 2001.
Yesavage JA: Ergoloid mesylates (Hydergine). In: Cummings JL, Miller BL, Alzheimer's Disease: Treatment and Long-Term Management. pp. 45-52, New York: Marcel Dekker, Inc., 1990.
Yesavage JA: Adverse drug side effects and interactions in the elderly. Second Seminar on Aging. Excerpta Medica, 1987.
Peabody CA, Thiemann S, Pigache R, Miller TP, Berger PA, Yesavage JA, Tinklenberg JR: Desglycinamide-9-Arginine-8-Vasopressin (DGAVP, Organon 5667) in patients with dementia. Neurobiology of Aging 6: 95-100, 1985.
Yesavage JA: Use of vasoactive medications in the treatment of senile dementia. In: B Reisberg (Ed), Alzheimer's Disease: The Standard Reference. pp. 374-386, New York: The Free Press, 1984.
Mills MJ, Pearsall DT, Yesavage JA, Salzman C: Electroconvulsive therapy in Massachusetts. American Journal of Psychiatry 141: 534-538, 1984.
Hollister LE, Yesavage JA: Ergoloid mesylates for senile dementias: Unanswered questions. Annals of Internal Medicine 100: 894-898, 1984.
Tinklenberg JR, Thornton JE, Yesavage JA: Clinical geriatric psychopharmacology and neuropeptides. In: CA Shamoian (Ed), Biology and Treatment of Dementia in the Elderly. pp. 74-90, Washington DC: American Psychiatric Press, 1984.
Yesavage JA: Dementias and drugs affecting cerebral blood flow. In: C Eisdorfer, E Fann (Eds), Treatment of Psychopathology in the Aging. pp. 127-136, New York: Springer Publishing Company, 1983.
Yesavage JA, Holman CA, Berger PA: Cerebrospinal fluid lactate levels and aging: Findings in normals and patients with major depressive disorders. Gerontology 28: 377-380, 1982.
Berens ES, Yesavage JA, Leirer VO: A comparison of multiple and single electroconvulsive therapy. Journal of Clinical Psychiatry 43: 126-128, 1982.
Yesavage JA, Holman CA, Sarnquist FH, Berger PA: Elevation of cerebrospinal fluid lactate with aging in subjects with normal blood oxygen saturations. Journal of Gerontology 37: 313-315, 1982.
Yesavage JA, Tinklenberg JR, Hollister LE, Berger PA: Effect of Nafronyl on lactate and pyruvate in the cerebrospinal fluid of patients with senile dementia. Journal of the American Geriatrics Society 30: 105-108, 1982.
Yesavage JA, Tinklenberg JR, Berger PA, Masson JM, Martin A, Bourgeois M: Traitement pharmacologique de la demence senile en Europe et aux U.S.A. Annales Medico-Psychologique 139: 21-28, 1981.
Yesavage JA, King R: Drug treatment of cognitive impairment in the elderly. In: C Eisdorfer (Ed), Annual Review of Gerontology and Geriatrics. pp. 199-210, New York: Springer Publishing Company, 1981.
Yesavage JA, Tinklenberg JR: Single-case study of clinical response to high-dose ergot alkaloid treatment for dementia. Preliminary report. Gerontology 27: 76-78, 1981.
Yesavage JA, Leirer VO, Becker L, Holman CA: Effect of an ergot preparation on cognitive ability and depression. Journal of Psychiatric Treatment and Evaluation 3: 153-156, 1981.
Yesavage JA, Berger PA: Correlation of cerebrospinal fluid lactate with age. American Journal of Psychiatry 137: 976-977, 1980.
Yesavage JA, Bourgeois ML, Cormier H, Tinklenberg JR, Berger PA, Hollister LE: Les medicaments vasodilatateurs dans le traitement des demences tardives: Revue critique de la litterature. Bordeaux Med 13: 1209-1219, 1980.
Yesavage JA, Bourgeois ML: Traitement medical de la deterioration mentale chez la femme agee. Bordeaux Med 13: 1221-1225, 1980.
Yesavage JA, Adey MB: Design aspects of clinical trials with ergot alkaloids: A comparison of two geriatric behavioral rating scales. In: M Goldstein, et al (Eds), Ergot Compounds and Brain Function: Neuroendocrine and Neuropsychiatric Aspects. pp. 357-362, New York: Raven Press, 1980.
Yesavage JA, Berens ES: Multiple monitored electroconvulsive therapy in the elderly. Journal of the American Geriatrics Society 28: 206-209, 1980.
Yesavage JA, Fill NA, Lapp D, Becker JMT, Mills MJ, Bourgeois M: Psychopathologie et traitement des psychotiques violents aux Etats Unis. Annales Medico-Psychologique 137: 760-763, 1979.
Yesavage JA, Tinklenberg JR, Hollister LE, Berger PA: Vasodilators in senile dementia: A review of the literature. Archives of General Psychiatry 36: 220-223, 1979.
Yesavage JA, Tinklenberg JR, Hollister LE, Berger PA: Vasodilators in senile dementia [letter to editor]. Archives of General Psychiatry 36: 220-223, 1979.
Davis KL, Mohs RC, Tinklenberg JR, Hollister LE, Yesavage JA, Kopell BS: The treatment of memory deficits in the aged with choline chloride. In: KL Davis, et al (Eds), Brain Acetylcholine and Neuropsychiatric Disease. pp. 253-264, New York: Plenum Press, 1979.
Davis KL, Yesavage JA: Brain acetylcholine and disorders of memory. In: KL Davis, et al (Eds), Brain Acetylcholine and Neuropsychiatric Disease. pp. 205-213, New York: Plenum Press, 1979.
Yesavage JA: Pharmacotherapy of the aged central nervous system. Clinical Neuropharmacology 4: 199-220, 1979.
Yesavage JA, Hollister LE, Burian E: Dihydroergotoxine: 6-mg vs 3-mg dosage in the treatment of senile dementia. Preliminary report. Journal of the American Geriatrics Society 27: 80-82, 1979.
Yesavage JA: Practical points in using dihydroergotoxine mesylate (Hydergine) in senile dementia. Psychiatric Annals 8: 74-83, 1978.
Yesavage JA, Hollister LE: The treatment of senile dementia. Rational Drug Therapy 12: 1-6, 1978.
Taylor JL, Mumenthaler MS O'Hara R, Yesavage JA: Assessments of expertise and working memory in predicting older pilots' performance of a simulated ATC communication task. Proceedings of the 12th International Symposium on Aviation Psychology (In Press).
Mumenthaler MS, Yesavage JA, Taylor JL, O'Hara R, Friedman L, Lee H, Kraemer HC: Psychoactive drugs and pilot performance: A comparison of nicotine, donepezil, and alcohol effects. Neuropsychopharmacology 28: 1366-1373, 2003.
Taylor JL, Mumenthaler MS, Kraemer HC, Noda A, O'Hara RM, Yesavage JA: Longitudinal study of older small-aircraft pilots: Changes in CogScreen-AE performance. In: R. S. Jensen, ed, Proceedings of the 11th International Symposium on Aviation Psychology. Columbus, Ohio: Ohio State University, 2002.
Mumenthaler MS, O'Hara R, Taylor JL, Friedman L, Yesavage JA: Influence of the menstrual cycle on flight simulator performance after alcohol ingestion. Journal of Studies on Alcohol 62: 422-433, 2001.
Yesavage JA, Mumenthaler M, Taylor JL, Friedman LF, O'Hara R, Sheikh J, Tinklenberg J, Whitehouse PJ: Donepezil and flight simulator performance: Effects on retention of complex skills. Neurology 59: 123-125, 2002.
Mumenthaler MS, Taylor JL, Yesavage JA: Ethanol pharmacokinetics in White women: Nonlinear model fitting vs zero-order elimination analyses. Alcoholism: Clinical and Experimental Research 24: , 2000.
Mumenthaler MS, Taylor JL, Yesavage JA: Abstract: Effects of menstrual cycle on alcohol metabolism and post-drink flight performance. 46th International Congress of Aviation and Space Medicine, Singapore, September 8vol. 46. 31, 1998.
Mumenthaler MS, Taylor JL, O'Hara R, Yesavage JA: Influence of nicotine on simulator flight performance in elderly non-smokers. Psychopharmacology 140: 38-41, 1998.
Mumenthaler MS, Taylor JL, Yesavage JA: Abstract: Nicotine's effect on fatigue and flight performance in drug-naive subjects. 45th International Congress of Aviation and Space Medicine, Oslo, Norway, August 28. 1997.
Taylor JL, Dolhert N, Friedman LF, Mumenthaler MS, Yesavage JA: Alcohol elimination and simulator performance of female and male aviators: A preliminary report. Aviation, Space, and Environmental Medicine 67: 407-413, 1996.
Taylor JL, Dolhert N, Morrow DG, Friedman LF, Yesavage JA: Acute and 8-hour effects of alcohol (0.08% BAC) on younger and older pilots' simulator performance. Aviation, Space, and Environmental Medicine 65: 718-725, 1994.
Taylor JL, Yesavage JA, Morrow DG, Dolhert N, Brooks JO, Poon LW: The effects of information load and speech rate on younger and older aircraft pilots' ability to execute air-traffic controller instructions. Journal of Gerontology: Psychological Sciences 49: 191-200, 1994.
Yesavage JA, Dolhert N, Taylor JL: Flight simulator performance of younger and older aircraft pilots: Effects of age and alcohol. Journal of the American Geriatrics Society 42: 577-582, 1994.
Yesavage JA, Taylor JL, Morrow D, Tinklenberg JR: The effects of alcohol on the variability of aircraft pilot performance. Alcohol, Drugs, and Driving 8: 217-224, 1993.
Morrow DG, Yesavage JA, Leirer V, Dolhert N, Taylor JL, Tinklenberg JR: The time-course of alcohol impairment of general aviation pilot performance in a Frasca 141 simulator. Aviation, Space, and Environmental Medicine 64: 697-705, 1993.
Morrow DG, Yesavage JA, Leirer VO, Tinklenberg JR: The influence of aging and practice on piloting tasks. Experimental Aging Research 19: 53-70, 1993.
Leirer VO, Yesavage JA, Morrow DG: Marijuana carry-over effects on aircraft pilot performance. Aviation, Space, and Environmental Medicine 62: 221-227, 1991.
Morrow DG, Leirer VO, Yesavage JA, Tinklenberg JR: Alcohol, age, and piloting: Judgment, mood, and actual performance. The International Journal of the Addictions 26: 669-683, 1991.
Morrow DG, Leirer V, Yesavage JA: The influence of alcohol and aging on radio communication during flight. Aviation, Space, and Environmental Medicine 61: 12-20, 1990.
Leirer VO, Yesavage JA, Morrow DG: Marijuana, aging, and task difficulty effects on pilot performance. Aviation, Space, and Environmental Medicine 60: 1145-1152, 1989.
Yesavage JA, Leirer VO: Hangover effects on aircraft pilots 14 hours after alcohol ingestion: A preliminary report. American Journal of Psychiatry 143: 1546-1550, 1986.
Yesavage JA, Leirer VO, Denari M, Hollister LE: Carryover effects of marijuana intoxication on aircraft pilot performance: A preliminary report. American Journal of Psychiatry 142: 1325-1329, 1985.
Brooks JO, Hoblyn JC, Kraemer HC, Yesavage JA: Factors associated with psychiatric hospitalization of dementia patients with comorbid bipolar disorder. Journal of Geriatric Psychiatry and Neurology (In press).
Yesavage JA, editor: Clozapine: A Compendium of Selected Readings, 4th ed. Sandoz Pharmaceuticals Corp, 1995.
Yesavage JA, editor: Clozapine: A compendium of selected readings, 3rd edition. Sandoz Pharmaceuticals, 1994.
Carmel H, Tanke ED, Yesavage JA: Physician staffing and patient violence. Bulletin of the American Academy of Psychiatry and Law 19: 49-51, 1991.
Werner PD, Rose TL, Yesavage, JA: Aspects of consensus in clinical predictions of imminent violence. Journal of Clinical Psychology 46: 534-538, 1990.
Yesavage JA, Brizer DA: Clinical and historical correlates of dangerous inpatient behavior. Current Approaches to the Predictions of Violence. Washington DC: American Psychiatric Press, Inc., 1989.
Yesavage JA, Widrow LA: Early parental discipline and adult self-destructive acts. Journal of Nervous and Mental Disease 173: 74-77, 1985.
Lawson WB, Yesavage JA, Werner PD: Race, violence, and psychopathology. Journal of Clinical Psychiatry 45: 294-297, 1984.
Isaacs JS, Yesavage JA: Serum creatine phosphokinase levels and assaultive behavior of psychotic patients. Psychological Medicine 14: 229-231, 1984.
Yesavage JA: Inpatient violence and the schizophrenic patient: A study of Brief Psychiatric Rating Scale scores and inpatient behavior. Acta Psychiatrica Scandinavica 67: 353-357, 1983.
Csernansky JG, Yesavage JA, Maloney W, Kaplan J: The treatment response scale: A retrospective method of assessing response to neuroleptics. American Journal of Psychiatry 140: 1210-1213, 1983.
Yesavage JA: Differential effects of Vietnam combat experiences versus criminality on dangerous behavior by Vietnam veterans with schizophrenia. Journal of Nervous and Mental Disease 171: 382-384, 1983.
Yesavage JA, Becker JMT, Werner PD, Patton M, Seeman K, Brunsting D, Mills MJ: Family conflict, psychopathology, and dangerous behavior by schizophrenic inpatients. Psychiatry Research 8: 271-280, 1983.
Yesavage JA, Benezech M, Bourgeois M, Mills MJ: Etude des correlations entre modes d'internement et comportement agressif dans une unite psychiatrique californienne. Annales Medico-Psychologique 137: 770-776, 1982.
Werner PD, Becker JMT, Yesavage JA, Isaacs JS: Analysis of responses to the Personal Opinion Survey by a sample of inpatients. Psychological Reports 51: 423-429, 1982.
Yesavage JA, Werner PD, Becker JMT, Holman CA, Mills MJ: Inpatient evaluation of aggression in psychiatric patients. Journal of Nervous and Mental Disease 169: 299-302, 1981.
Benezech M, Bourgeois M, Yesavage JA: Violence in the mentally ill: A study of 547 patients at a French hospital for the criminally insane. Journal of Nervous and Mental Disease 168: 698-700, 1980.
Yesavage JA, Fill NM, Rosenbaum CP: Psychopharmacology in the setting of a psychiatric intensive care unit. Psychopharmacology Bulletin 16: 14-15, 1980.
Yesavage JA: Fenetre therapeutique des taux de neuroleptics dans les hematics des schizophrenes. Annales Medico-Psychologique 137: 251, 1979.
Masson JM, Martin A, Arlot JC, Yesavage JA: Fluphenazine decanoate: Fifty cases over seven years - A report. Psychopharmacology Bulletin 14: 8-9, 1978.
Fountoulakis KN, O'Hara R, Iacovides A, Camilleri CP, Kaprinis S, Kaprinis G, Yesavage J: Unipolar late-onset depression: A comprehensive review. Ann Gen Hosp Psychiatry2(1):11, 2003
Yesavage JA, Hoblyn J, Sheikh J, Tinklenberg JR, Noda A, O'Hara R, Fenn C, Mumenthaler MS, Friedman L, Kraemer HC: Age and disease severity predict choice of atypical neuroleptic: a signal detection approach to physicians' prescribing decisions. J Psychiatr Res37(6):535-8, 2003
Zeiss RA, Tanke ED, Fenn HH, Yesavage JA: Dangerousness commitments: Indices of future violence potential?. Bulletin of the American Academy of Psychiatry and Law 24: 247-253, 1996.
Benezech M, Bourgeois M, Yesavage JA: Cannibalism and vampirism in paranoid schizophrenia. In: Richard Noll, Vampires werewolves, and demons: Twentieth century reports in the psychiatric literarure. pp. 57 -60, New York, NY, USA: Brunner/Mazel, Inc., 1992.
Werner PD, Rose TL, Murdach AD, Yesavage JA: Social workers' decision making about the violent client. Social Work Research and Abstracts 25: 17-20, 1989.
Seeman K, Widrow L, Yesavage JA: Fantasized companions and suicidal depressions. In: L Stanley, What we know about suicidal behavior and how to treat it. pp. 133 - 156, Northvale, NJ, USA: Jason Aronson, Inc., 1988.
Sheikh JI, Yesavage JA: Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. In: , Clinical Gerontology : A Guide to Assessment and Interventionvol. 5. pp. 165-173, NY: The Haworth Press, 1986.
Yesavage JA, Benezech M, Larrieu-Arquille R, Bourgeois M, Tanke E, Rager R, Mills MJ: Recidivism of the criminally insane in France: A 22-year follow-up. Journal of Clinical Psychiatry 47: 465-466, 1986.
Tanke ED, Yesavage JA: Characteristics of assaultive patients who do and do not provide visible cues of potential violence. American Journal of Psychiatry 142: 1409-1413, 1985.
Seeman K, Yesavage JA, Widrow LA: Correlations of self-directed violence in acute schizophrenics with clinical ratings and personality measures. Journal of Nervous and Mental Disease 173: 298-302, 1985.
Werner PD, Rose TL, Yesavage JA, Seeman K: Psychiatrists' judgments of dangerousness in patients on an acute care unit. American Journal of Psychiatry 141: 263-266, 1984.
Seeman K, Widrow LA, Yesavage JA: Fantasized companions and suicidal depressions: Two case reports. American Journal of Psychotherapy 38: 541-557, 1984.
Yesavage JA: A study of mandatory review of civil commitment. Archives of General Psychiatry 41: 305-308, 1984.
Benezech M, Yesavage JA, Addad M, Bourgeois M, Mills M: Homicide by psychotics in France: A five-year study. Journal of Clinical Psychiatry 45: 85-86, 1984.
Yesavage JA: Correlates of dangerous behavior by schizophrenics in hospital. Journal of Psychiatric Research 18: 225-231, 1984.
Yesavage JA: Control of dangerous behavior of schizophrenics in hospital. Management of the Acute Psychiatric Emergency: Proceedings of a Symposium. New York: Roerig Pharmaceuticals, 1984.
Yesavage JA: Direct and indirect hostility and self-destructive behavior by hospitalized depressives. Acta Psychiatrica Scandinavica 68: 345-350, 1983.
Mills MJ, Yesavage JA, Gutheil TG: Continuing case-law development in the right to refuse treatment. American Journal of Psychiatry 140: 715-719, 1983.
Yesavage JA: Dangerous behavior by Vietnam veterans with schizophrenia. American Journal of Psychiatry 140: 1180-1183, 1983.
Yesavage JA, Holman CA, Cohn R, Lombroso L: Correlation of initial thiothixene serum levels and clinical response: Comparison of fluorometric, gas chromatographic and RBC assays. Archives of General Psychiatry 40: 301-304, 1983.
Yesavage JA: Relationships between measures of direct and indirect hostility and self-destructive behavior by hospitalized schizophrenics. British Journal of Psychiatry 143: 173-176, 1983.
Yesavage JA: Bipolar illness: Correlates of dangerous inpatient behavior. British Journal of Psychiatry 143: 554-557, 1983.
Yesavage JA, Benezech M, Ceccaldi P, Bourgeois M, Addad M: Arson in mentally ill and criminal populations. Journal of Clinical Psychiatry 44: 128-130, 1983.
Werner PD, Rose TL, Yesavage JA: Reliability, accuracy, and decision-making strategy in clinical predictions of imminent dangerousness. Journal of Consulting and Clinical Psychology 51: 815-825, 1983.
Werner PD, Yesavage JA, Becker JMT, Brunsting DW, Isaacs JS: Hostile words and assaultive behavior on an acute inpatient psychiatric unit. Journal of Nervous and Mental Disease 171: 385-387, 1983.
Yesavage JA, Portnoff LA, Rose TL: Auditory versus memory deficits in paranoid and chronic undifferentiated schizophrenia. Journal of Psychiatric Treatment and Evaluation 5: 309-314, 1983.
Portnoff LA, Yesavage JA, Acker M: Active and passive attentional deficits in paranoid and undifferentiated schizophrenics. Psychological Reports : , 1983.
Werner PD, Becker JMT, Yesavage JA: Concurrent validity of the overcontrolled hostility scale for psychotics. Psychological Reports 52: 93-94, 1983.
Yesavage JA, Werner PD, Becker JMT, Mills M: Short-term civil commitment and the violent patient. American Journal of Psychiatry 139: 1145-1149, 1982.
Yesavage JA, Becker JMT, Werner PD, Mills MJ, Holman CA, Cohn R: Serum level monitoring of thiothixene in schizophrenia: Acute single-dose levels at fixed doses. American Journal of Psychiatry 139: 174-178, 1982.
Yesavage JA, Werner PD, Becker JMT, Seeman K: Drift and dangerousness: Social class differences between acute schizophrenics and their parents in relation to measures of violence. British Journal of Psychiatry 141: 267-270, 1982.
Yesavage JA, Werner PD, Becker JMT, Mills MJ: The context of involuntary commitment on the basis of danger to others: A study of the use of the California 14-day certificate. Journal of Nervous and Mental Disease 170: 622-627, 1982.
Csernansky JG, Grabowski K, Cervantes J, Kaplan J, Yesavage JA: Fluphenazine decanoate and tardive dyskinesia: A possible association. American Journal of Psychiatry 138: 1362-1365, 1981.
Benezech M, Bourgeois M, Boukhabza D, Yesavage JA: Cannibalism and vampirism in paranoid schizophrenia. Journal of Clinical Psychiatry 42: 290, 1981.
Addad M, Benezech M, Bourgeois M, Yesavage JA: Criminal acts among schizophrenics in French mental hospitals. Journal of Nervous and Mental Disease 169: 289-293, 1981.
Portnoff LA, Yesavage JA, Acker L: Visual search performance by paranoid and chronic undifferentiated schizophrenia. Perceptual and Motor Skills 53: 411-418, 1981.
Yesavage JA, Holman CA, Cohn R: Correlation of thiothixene serum levels and age. Psychopharmacology 74: 170-172, 1981.
Bourgeois M, Yesavage JA, Benezech M, Mas F: Vers une pratique defensive de la psychiatrie. Annales Medico-Psychologique 138: 566-574, 1980.
Silva JA, Yesavage JA: Covariance of affective and schizophrenic symptoms in schizoaffective psychosis. Journal of Nervous and Mental Disease 168: 559-561, 1980.
Calil HM, Yesavage JA, Hollister LE: Low dose levadopa in schizophrenia. Communications in Psychopharmacology 1: 593-596, 1977.
Yesavage JA, Sheikh JS, Noda A, Murphy G, O'Hara R, Hierholzer R, Battista M, Ashford JW, Schnieder B, Hoblyn J, Kraemer HC, Tinklenberg JR: Spatial test of the effects of agricultural pesticide "blow on" effect on prevalence of Parkinson's disease. Journal of Geriatric Psychiatry and Neurology 19: 1-3, 2006.
Rosen CS, Chow HC, Finney JF, Greenbaum MA, Moos RH, Sheikh JI, Yesavage JA: VA practice patterns and practice guidelines for treating posttraumatic stress disorder. J Trauma Stress17(3):213-22, 2004
Yesavage JA, Sheikh J, Noda A, Murphy G, O'Hara R, Hierholzer R, Battista M, Ashford JW, Kraemer HC, Tinklenberg J: Use of a VA pharmacy database to screen for areas at high risk for disease: Parkinson's disease and exposure to pesticides. J Geriatr Psychiatry Neurol17(1):36-8, 2004
Mumenthaler MS, O'Hara R, Taylor JL, Friedman L, Yesavage JA: Relationship between variations in estradiol and progesterone levels across the menstrual cycle and human performance. Psychopharmacology 155: 198-203, 2001.
Friedlander AL, Butterfield GE, Moynihan S, Grillo J, Pollack M, Holloway L, Friedman L, Yesavage J, Matthias D, Lee S, Marcus R, Hoffman AR: One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 86: 1496-1503, 2001.
Bandeen-Roche K, Wang J-L, Hogan JW, Daniels M, Tiling K, O'Hara R, Kraemer HC, Taylor JL, Noda A, Yesavage JA: Abstract: From the experimental to the clinical and beyond: New quantitative methods for research on aging. Gerontological Society of America Annual Scientific Meeting, Nov 17, 2000. (Accepted for Publication).
Mumenthaler MS, Taylor JL, O'Hara R, Yesavage JA: Abstract: Alcohol elimination in women and its correlation with drinking history. Alcoholism: Clinical and Experimental Researchvol. 24. 63A, 2000.
Mumenthaler MS, Taylor JL, O'Hara R, Yesavage JA: Gender differences in moderate drinking effects. Alcohol Research & Health 23: 55-64, 1999.
Mumenthaler MS, Taylor JL, O'Hara R, Fisch HU, Yesavage JA: Effects of menstrual cycle and female sex steroids on ethanol pharmacokinetics. Alcoholism: Clinical and Experimental Research 23: 250-255, 1999.
Fenn HH, Robinson D, Luby V, Dangel C, Buxton E, Beattie M, Kraemer HC, Yesavage JA: Trends in maintenance pharmacotherapy of schizoaffective and bipolar patients: A five-year naturalistic study. American Journal of Psychiatry 153: 711-713, 1996.
Robinson D, Fenn HH, Yesavage JA: Possible association of parotitis with clozapine [letter to editor]. American Journal of Psychiatry 152: 297-298, 1995.
Robinson D, Yesavage JA, Tinklenberg JR: Diabetic neuropathy and possible treatment [letter to editor]. Journal of the American Geriatrics Society 42: 570-571, 1994.
Yesavage JA: Western medications needed in Lithuania [letter to editor]. American Journal of Psychiatry 150: 1275, 1993.
Leirer VO, Yesavage JA, Morrow DG: Marijuana carry-over effects on psychomotor performance. In: , Proceedings: A Chronicle of Research. National Academy of Medicine, Text and Documents. International Science Colloquium, Les Drogues Illicites. Paris, April 8-9. pp. 49-62, : National Academy of Medicine, 1992.
Yesavage JA: APA Council Reports: The Council on Aging. American Journal of Psychiatry 147: 382, 1990.
Yesavage JA, Berger PA: Correction to a 1980 Article on CSF Lactate and Age. American Journal of Psychiatry 146: 118, 1989.
Sheikh JI, Yesavage JA, Gulevich G: Practical geriatrics: Validation of the Geriatric Psychiatry Knowledge test. Hospital and Community Psychiatry 39: 369, 375, 1988.
Yesavage JA: Carry-over effects of marijuana: Dr. Yesavage replies. American Journal of Psychiatry 144: 260, 1987.
Yesavage JA, Tanke ED, Sheikh JI: Tardive dyskinesia and steady-state serum levels of thiothixene. Archives of General Psychiatry 44: 913-915, 1987.
Sheikh JI, Yesavage JA: Geriatric Knowledge Test: Reply. Hospital and Community Psychiatry 37: 403, 1986.
Yesavage JA: Psychotropic blood levels: A guide to clinical response. Symposium on Issues Concerning the Bioavailability and Bioequivalence of Psychotropic Drugs (1985, Sonoma, California). Journal of Clinical Psychiatry (Suppl) 47: 16-19, 1986.
Yesavage JA, Davidson J, Widrow LA, Berger PA: Plasma testosterone levels, depression, sexuality, and age. Biological Psychiatry 20: 199-228, 1985.
Sheikh JI, Yesavage JA: A Knowledge Assessment Test for geriatric psychiatry. Hospital and Community Psychiatry 36: 1160-1161, 1985.
Sheikh JI, Yesavage JA: Geriatric Psychiatry Knowledge Test, Form 1. Hospital and Community Psychiatry 36: 1162-1166, 1985.
Sheikh JI, Yesavage JA: Geriatric Psychiatry Knowledge Test, Form 2. Hospital and Community Psychiatry 36: 1271-1275, 1985.
Yesavage JA: Neuroleptic plasma levels as correlates of violence in schizophrenic patients. Violence: Psychiatric and Legal Issues: A Symposium. : Roerig/Pfizer,, 1985.
Bourgeois M, Tignol J, Saubech JF, Dauloude JP, Yesavage JA: Anesthetic electrical self-stimulation (electrotherapy) as an adjunct to narcotics withdrawal [letter to editor]. Journal of Clinical Psychiatry : 1984.
Yesavage JA: Plasma levels as predictors of clinical response and violent behavior. Journal of Clinical Psychiatry Monograph Series 2: 13-20, 1984.
Yesavage JA, Zarcone VA: History of drug abuse and dangerous behavior in inpatient psychotics. Journal of Clinical Psychiatry 44: 259-261, 1983.
Yesavage JA: Inpatient violence and the schizophrenic patient: An inverse correlation between danger-related events and neuroleptic levels. Biological Psychiatry 17: 1331-1337, 1982.
Stahl SM, Yesavage JA, Berger PA: Pharmacologic characteristics of Meige Dystonia: Differentiation from tardive dyskinesia. Journal of Clinical Psychiatry 43: 445-446, 1982.
Yesavage JA, Bourgeois ML, Kraemer HC, Csernansky JG, Berger PA: Prevalence of tardive dyskinesia in 3140 French inpatients. Journal of Nervous and Mental Disease 170: 111-112, 1982.
Brink TL, Yesavage JA: Somatoform disorders: Differentiation of conversion, hypochondriacal, psychophysiologic, and related disorders. Postgraduate Medicine 72: 189-198, 1982.
Walker S, Yesavage JA, Tinklenberg JR: Acute phencyclidine (PCP) intoxication: Quantitative urine levels and clinical management. American Journal of Psychiatry 138: 674-675, 1981.
Bourgeois M, Bouilh P, Tignol J, Yesavage JA: Spontaneous dyskinesias versus neuroleptic-induced dyskinesias in 270 elderly subjects. Journal of Nervous and Mental Disease 168: 177-178, 1980.
Yesavage JA, Freeman AM: PCP, neurochemistry, treatment, and more [letter to editor]. American Journal of Psychiatry 136: 235-236, 1979.
Yesavage JA, Slater P, Berger PA: Repertory grid and biochemical characterization of depression: A comparison of case reports. Journal of Clinical Psychiatry 40: 232-235, 1979.
Yesavage JA, Freeman AM: Acute phencyclidine (PCP) intoxication: Psychopathy and prognosis. Journal of Clinical Psychiatry 39: 664-666, 1978.
Davis KL, Yesavage JA, Berger PA: Single case study: Possible organophosphate-induced Parkinsonism. Journal of Nervous and Mental Disease 166: 222-225, 1978.
Yesavage JA, Freeman AM, Bourgeois M: Time distortion in acute phencyclidine (PCP) psychosis: A correlation between 30 second estimation and urine drug levels.. L'Encephale 4: 281-285, 1978.